From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents?
- PMID: 32150469
- DOI: 10.1161/CIRCULATIONAHA.119.045256
From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents?
Keywords: atherosclerosis; cholesterol, LDL; colchicine; combination therapy; hydoxymethylglutaryl-CoA reductase inhibitors; inflammation.
Comment in
- 
  
  Editorial commentary: Embracing colchicine as a new cornerstone therapy for coronary disease.Trends Cardiovasc Med. 2021 Nov;31(8):505-506. doi: 10.1016/j.tcm.2020.10.012. Epub 2020 Nov 3. Trends Cardiovasc Med. 2021. PMID: 33157208 No abstract available.
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
        